Qodebook Right Code · Any Purpose

Atosiban acetate

Commodity a leaf — nothing below it, 8 links to KBLI

Level
Commodity
Parent
51182200
Below
0
Links · KBLI
8

Definition

UNSPSC 51182215

This classification denotes the acetate form of a hormone antagonist with the molecular formula C43H67N11O12S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 081D12SI0Z, chemically known as oxytocin, 1-(3-mercaptopropanoic acid)-2-(o-ethyl-d-tyrosine)-4-l-threonine-8-l-ornithine- but generally known as atosiban, which bears US NIH Compound Identifier 68613. European Medicines Agency schedules Atosiban in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05601MIG. The term ATOSIBAN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 3, No. 3, 1989, List 29). World Health Organization schedules atosiban in its Anatomical Therapeutic Chemical (ATC) Classification. ATOSIBAN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. The base compound, atosiban, is a hormone antagonist with the molecular formula C43H67N11O12S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 081D12SI0Z, chemically known as oxytocin, 1-(3-mercaptopropanoic acid)-2-(o-ethyl-d-tyrosine)-4-l-threonine-8-l-ornithine- but generally known as atosiban, which bears US NIH Compound Identifier 68613. European Medicines Agency schedules Atosiban in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05601MIG. The term ATOSIBAN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 3, No. 3, 1989, List 29). World Health Organization schedules atosiban in its Anatomical Therapeutic Chemical (ATC) Classification. ATOSIBAN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule atosiban acetate under HS 29349990 and SITC 51579. As of Q4 2014, ATOSIBAN ACETATE remains the US FDA Preferred Term for this commodity. Atosiban acetate bears US NLM identifiers UMLS ID C0873206 and NCI Concept Code C97706. SMILES: S1SCCC(=O)NC(C(=O)NC(C(CC)C)C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2C(CCC2)C(=O)NC(CCCN)C(=O)NCC(=O)N)C1)CC(=O)N)C(O)C)CC1CCC(OCC)CC1.

Same parent

Under 51182200 · 23
51182201 Dinoprostone Commodity 51182202 Methylergometrine or methylergonovine Commodity 51182203 Oxytocin Commodity 51182204 Ergometrine or ergonovine Commodity 51182205 Doxaprost Commodity 51182206 Atosiban Commodity 51182207 Carbetocin Commodity 51182208 Carboprost Commodity 51182209 Deaminooxytocin or demoxytocin Commodity 51182210 Dinoprost Commodity 51182211 Epostane Commodity 51182212 Mepitiostane Commodity 51182213 Meteneprost Commodity 51182214 Misoprostol Commodity 51182215 Atosiban acetate You are here 51182216 Carboprost methyl Commodity 51182217 Carboprost methyl ester Commodity 51182218 Carboprost trometamol Commodity 51182219 Carboprost tromethamine Commodity 51182220 Dinoprost trometamol Commodity 51182221 Dinoprost tromethamine Commodity 51182222 Ergometrine maleate Commodity 51182223 Oxytocin citrate Commodity

Activities that produce or sell this

KBLI · 8

Inherited from family 51180000.

21012 Industri Produk Farmasi untuk Manusia Sub-class 21013 Industri Produk Farmasi untuk Hewan Sub-class 46441 Perdagangan Besar Sediaan Farmasi untuk Manusia Sub-class 46442 Perdagangan Besar Sediaan Farmasi untuk Hewan Sub-class 46902 Perdagangan Besar Berbagai Macam Barang Selain di Grosir/Perkulakan Swalayan Sub-class 47721 Perdagangan Eceran Sediaan Farmasi untuk Manusia di Apotek Sub-class 47722 Perdagangan Eceran Sediaan Farmasi untuk Manusia Selain di Apotek Sub-class 47726 Perdagangan Eceran Obat Farmasi untuk Hewan Sub-class

Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.